These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35422624)

  • 1. The Use of Muscle Relaxants and Reversal Agents in a Setting Without Cost Restrictions: Experience from a Tertiary Academic Hospital in the Netherlands.
    Martini CH; Honing GHM; Bash LD; Olofsen E; Niesters M; van Velzen M; Dahan A; Boon M
    Ther Clin Risk Manag; 2022; 18():379-390. PubMed ID: 35422624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
    Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
    Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of recovery after sugammadex or neostigmine reversal of rocuronium in geriatric patients undergoing spine surgery: a randomized controlled trial.
    Mraovic B; Timko NJ; Choma TJ
    Croat Med J; 2021 Dec; 62(6):606-613. PubMed ID: 34981693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-Based Neurointerventional Procedures: A Randomized Trial.
    Farag E; Rivas E; Bravo M; Hussain S; Argalious M; Khanna S; Seif J; Pu X; Mao G; Bain M; Elgabaly M; Esa WAS; Sessler DI
    Anesth Analg; 2021 Jun; 132(6):1666-1676. PubMed ID: 34032663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study.
    An J; Lee JH; Kim E; Woo K; Kim H; Lee D
    Medicine (Baltimore); 2020 Feb; 99(7):e19130. PubMed ID: 32049831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery.
    Boon M; Martini C; Yang HK; Sen SS; Bevers R; Warlé M; Aarts L; Niesters M; Dahan A
    PLoS One; 2018; 13(5):e0197036. PubMed ID: 29791482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis.
    Jakubiak J; Gaszyński T; Gaszyński W
    Anaesthesiol Intensive Ther; 2012; 44(1):28-30. PubMed ID: 23801510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.
    Carron M; Baratto F; Zarantonello F; Ori C
    Clinicoecon Outcomes Res; 2016; 8():43-52. PubMed ID: 26937203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of neuromuscular blockade by sugammadex in laparoscopic bariatric surgery: In support of dose reduction.
    Badaoui R; Cabaret A; Alami Y; Zogheib E; Popov I; Lorne E; Dupont H
    Anaesth Crit Care Pain Med; 2016 Feb; 35(1):25-29. PubMed ID: 26597732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study.
    Krijtenburg P; de Boer A; Bash LD; Scheffer GJ; Keijzer C; Warlé MC
    Perioper Med (Lond); 2024 Mar; 13(1):22. PubMed ID: 38539254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.